Oct 17th 2013 - Edison Investment Research today published a report on Aap Implantate AG (AAQ.L, LSE:AAQ, LON:AAQ) entitled "Unlocking Loqteq's Potential". In summary, the report says:
Continued roll-out of the Loqteq trauma plates should help cement aap's position as a specialised medtech player, aided by strategic relationships with physicians and global medtech partnerships. Loqteq's innovative design should drive uptake in a >$1bn market, owing to increased flexibility for surgeons, potential clinical advantages and cost benefits for payors. We value aap at €3.3/share based on a DCF.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »